More than 100,000 individuals across the nation learned about hands-only CPR through training kiosks since the American Heart Association (AHA), along with Anthem Foundation, launched its program in 2016.

Chagas disease—the result of infection with a parasite called Trypanosoma cruzi (T cruzi)—causes heart disease, including heart failure, stroke, arrhythmia and sudden death in one-third of those infected, according to a scientific statement issued by the American Heart Association and the Inter-American Society of Cardiology.

The factor Xa inhibitor edoxaban might reduce the risk of several adverse events—including stroke, major bleeding and all-cause death—when compared to warfarin, according to a real-world study of Korean patients with atrial fibrillation (AFib).

Japanese researchers believe they’ve identified a genetic risk marker that could pinpoint which people with atrial fibrillation (AFib) are at risk of developing tachycardia-induced cardiomyopathy.

A screening program for top teen soccer players in England identified heart disorders associated with sudden cardiac death in one out of every 266 individuals. But among the eight athletes who eventually died of sudden cardiac arrest, six of them had normal electrocardiographic and echocardiographic findings.

Medtronic has launched the pilot study of its extravascular implantable cardioverter defibrillator (EV ICD), which is designed to deliver defibrillation and antitachycardia pacing without transvenous leads.

Atrial fibrillation (AFib) and atrial flutter (AFL) are often regarded as interchangeable when informing the management of stroke risk. However, a new study in JAMA Network Open suggests clinical outcomes are worse for patients with AFib, even if they have the same values on the standard CHA2DS2-VASc scoring system.

A New Jersey cardiologist specializing in electrophysiology was sentenced July 31 to 20 months in prison for billing the Veterans Affairs (VA) program hundreds of thousands of dollars for services he never performed.